ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial.

This study has been completed.

Study NCT00051493 Information provided by Eli Lilly and Company

First Received: January 10, 2003 Last Updated: July 18, 2006 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	December 2002
Estimated Primary Completion Date:	No date given